Unilever investment
This article was originally published in The Rose Sheet
Executive Summary
Unilever dedicating nearly $170 mil. to corporate ventures to build business opportunities in food and home and personal care, company announces Sept. 30. Majority of the funding - nearly $100 mil. - will be dedicated to Langholm Capital Partners Fund, which will target investments in mid-market European consumer-facing businesses, Unilever says. Additionally, firm will invest almost $40 mil. over three years in Unilever Ventures, "an early stage business development fund supporting early stage business ideas," company says. Nearly $30 mil. will be used to identify and invest in technology-based funds and start up companies via Unilever Technology Ventures. Goal is to "enhance the scope and quality of Unilever's own R&D activities by exploiting new technologies," company says, noting areas of investment will include genomics, advanced bioscience, advanced materials science and nanotechnology...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.